KR100808060B1 - Microorganism having fermentation activity of cervi parvum cornu and process for the preparation of fermentation product of cervi parvum cornu using the same - Google Patents
Microorganism having fermentation activity of cervi parvum cornu and process for the preparation of fermentation product of cervi parvum cornu using the same Download PDFInfo
- Publication number
- KR100808060B1 KR100808060B1 KR1020070114060A KR20070114060A KR100808060B1 KR 100808060 B1 KR100808060 B1 KR 100808060B1 KR 1020070114060 A KR1020070114060 A KR 1020070114060A KR 20070114060 A KR20070114060 A KR 20070114060A KR 100808060 B1 KR100808060 B1 KR 100808060B1
- Authority
- KR
- South Korea
- Prior art keywords
- antler
- fermentation
- bacillus
- test group
- strain
- Prior art date
Links
- 230000000694 effects Effects 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims abstract description 11
- 238000000855 fermentation Methods 0.000 title claims description 56
- 230000004151 fermentation Effects 0.000 title claims description 56
- 244000005700 microbiome Species 0.000 title description 2
- 230000008569 process Effects 0.000 title description 2
- 238000002360 preparation method Methods 0.000 title 1
- 241000194108 Bacillus licheniformis Species 0.000 claims abstract description 18
- 238000001035 drying Methods 0.000 claims abstract description 12
- 210000003056 antler Anatomy 0.000 claims description 96
- 241000209094 Oryza Species 0.000 claims description 31
- 235000007164 Oryza sativa Nutrition 0.000 claims description 31
- 235000009566 rice Nutrition 0.000 claims description 31
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 28
- 238000004108 freeze drying Methods 0.000 claims description 12
- 239000012736 aqueous medium Substances 0.000 claims description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 claims 1
- 206010012735 Diarrhoea Diseases 0.000 abstract description 12
- 230000002929 anti-fatigue Effects 0.000 abstract description 9
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- 230000001681 protective effect Effects 0.000 abstract description 2
- 230000008021 deposition Effects 0.000 abstract 1
- 230000008014 freezing Effects 0.000 abstract 1
- 238000007710 freezing Methods 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 50
- 239000000047 product Substances 0.000 description 23
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 22
- 241000282994 Cervidae Species 0.000 description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- 238000004519 manufacturing process Methods 0.000 description 13
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 230000000144 pharmacologic effect Effects 0.000 description 8
- 230000009182 swimming Effects 0.000 description 8
- 238000011084 recovery Methods 0.000 description 7
- 244000063299 Bacillus subtilis Species 0.000 description 6
- 235000014469 Bacillus subtilis Nutrition 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 4
- 108010082126 Alanine transaminase Proteins 0.000 description 4
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 4
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 4
- 206010067125 Liver injury Diseases 0.000 description 4
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 4
- 231100000234 hepatic damage Toxicity 0.000 description 4
- 239000010903 husk Substances 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 4
- 230000008818 liver damage Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000002443 hepatoprotective effect Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 230000000721 bacterilogical effect Effects 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229960003624 creatine Drugs 0.000 description 2
- 239000006046 creatine Substances 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 210000003736 gastrointestinal content Anatomy 0.000 description 2
- 230000002489 hematologic effect Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 229940124595 oriental medicine Drugs 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000001974 tryptic soy broth Substances 0.000 description 2
- 239000006150 trypticase soy agar Substances 0.000 description 2
- 108010050327 trypticase-soy broth Proteins 0.000 description 2
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- PKVZBNCYEICAQP-UHFFFAOYSA-N Mecamylamine hydrochloride Chemical compound Cl.C1CC2C(C)(C)C(NC)(C)C1C2 PKVZBNCYEICAQP-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 241000283011 Rangifer Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000009603 aerobic growth Effects 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 230000009604 anaerobic growth Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- -1 for example Substances 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000002766 immunoenhancing effect Effects 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 231100000668 minimum lethal dose Toxicity 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 1
- 229960004245 silymarin Drugs 0.000 description 1
- 235000017700 silymarin Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/20—Meat products; Meat meal; Preparation or treatment thereof from offal, e.g. rinds, skins, marrow, tripes, feet, ears or snouts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/07—Bacillus
- C12R2001/10—Bacillus licheniformis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
본 발명은 녹용 발효 활성을 갖는 균주 및 이를 이용한 녹용 발효물의 제조방법에 관한 것으로, 더욱 상세하게는 녹용 발효 활성을 갖는 신규의 바실러스 리케니포르미스 (Bacillus licheniformis) 및 이를 이용한 녹용 발효물의 제조방법에 관한 것이다.The present invention relates to a strain having a deer antler fermentation activity and a method for producing a deer antler fermentation using the same, more specifically, Bacillus rickenformis ( Bacillus) having a deer antler fermentation activity licheniformis ) and a method for producing a antler fermented product using the same.
녹용(라틴명 cervi parvum cornu)은 사슴과(cervidae)에 속하는 매화록, 마록 또는 기타 종속의 수사슴의 머리에 난 골질화되지 않은 어린 뿔을 말한다. 녹각은 골질화된 뿔을 녹각이라고 하며, 이듬해 저절로 떨어진 것을 낙각이라고 한다. 녹용은 산지 및 사슴의 종류에 따라 마록, 매화록, 시베리아산 대록, 뉴질랜드 산 직록, 순록 등으로 구분된다. Deer antler (Latin cervi parvum cornu) refers to the young, unosteophilized horn on the head of a plum, marok, or other dependent stag, belonging to the cervidae family. The rusted horn is called rusted horn, and the following year it is called a fall. Deer antler is divided into manok, plum, siberian, and NZ, and reindeer, depending on the type of mountain and deer.
한방에서는 녹용을 예로부터 최고의 보혈 강장제로 여겨왔으며, 동의보감 등의 문헌에 수록된 바와 같이 녹용에는 강장작용, 보기혈작용, 강정작용, 진통작용, 조혈작용, 생장발육촉진작용, 심부전증 치료작용 및 기능항진작용 등이 있으며, 이밖에도 피로회복, 신체활력증강, 및 신기능 강화 등 다양한 효능을 갖고 있는 것으로 알려져 있다. In oriental medicine, deer antler has long been considered the best tonic tonic, and as described in Dong Bok-gam's literature, antler has tonic action, view blood action, gangjeong action, analgesic action, hematopoietic action, growth development promotion, heart failure treatment and hyperactivity. It is known to have various effects such as fatigue recovery, physical vitality enhancement, and renal function enhancement.
그러나, 녹용은 설사 등의 부작용이 있어, 한방에서 수렴작용이 있는 한약과 병용하여 사용하게 되는데, 이 경우 기대했던 효과가 상실되거나 감소될 수 있다. 또한, 한방의 유용한 자원인 녹용은 한약에 이용하기 위해 알코올에 담근 후, 이를 세절하여 사용하게 되는데, 이 과정에서 녹용의 많은 유효성분이 소실되고 있다. However, deer antler has side effects such as diarrhea, it is used in combination with herbal medicine with astringent action in the herbal, in which case the expected effect may be lost or reduced. In addition, antler, which is a useful resource of oriental medicine, is dipped in alcohol for use in Chinese medicine, and then used in small pieces. In this process, many active ingredients of antler are lost.
한편, 녹용을 바실러스속 균주 등을 이용하여 발효시킬 경우 면역증강 효과가 우수한 녹용 발효물이 얻어질 수 있다는 것이 공지된 바 있다. On the other hand, it is known that when the antler is fermented using a Bacillus strain or the like, a antler fermented product having an excellent immune enhancing effect can be obtained.
대한민국 특허등록 제206,182호는 동물의 장내용물 또는 신선한 변으로부터 분리된 녹용분해 활성을 갖는 바실러스속 Py-92균주(KCTC 0049 BP)를 개시한 바 있다 (생약학회지 1994; 25: 233-237, 약학회지 12994; 38: 795-799). 또한, 대한민국 특허등록 제329,365호는 녹용(또는 녹각)을 계내금과 함께 발효시킴으로써 그 흡수율을 증가시킨 녹용제제 및 그의 제조방법을 개시한 바 있다. 또한, 대한민국 특허공개 제10-2006-0128117호는 녹용 중량의 약 10 내지 60배 분량의 증류수에 분쇄한 녹용을 넣어 멸균하여 만든 녹용배지에 바실러스 P-92균주를 이식하여 5 내지 7일간 배양한 후 멸균 및 여과하는 과정에 의해 수득되는 발효 녹용 추출물을 유효성분으로 함유하는 면역증강, 장기능 강화와 암예방 및 치료용 약학 조성물을 개시한 바 있다.Korean Patent Registration No. 206,182 discloses Bacillus Py-92 strain (KCTC 0049 BP) having antler degradation activity isolated from animal intestinal contents or fresh stools (KCTC 1994; 25: 233-237, about Journal 12994; 38: 795-799). In addition, Republic of Korea Patent No. 329,365 discloses a antler solvent and a method of manufacturing the same by increasing the absorption rate by fermenting the antler (or rust) together with the system. In addition, Republic of Korea Patent Publication No. 10-2006-0128117 No. 10-2006-0128117 was cultured for 5 to 7 days by implanting Bacillus P-92 strain in a antler medium made by putting the antler pulverized in about 10 to 60 times the amount of antler weight distilled water It has been disclosed a pharmaceutical composition for immuno-enhancing, intestinal function and cancer prevention and treatment containing the fermented antler extract obtained by the post sterilization and filtration process as an active ingredient.
기타, 대한민국 특허등록 제753,776호는 녹용 엑기스를 첨가하여 제조한 발 효식품 및 그 제조방법을 개시한 바 있다.In addition, Korean Patent Registration No. 753,776 discloses a fermented food prepared by adding an antler extract and a method of manufacturing the same.
그러나, 종래의 방법, 예를 들어 동물의 장내용물 또는 신선한 변으로부터 분리된 바실러스속 Py-92균주(KCTC 0049 BP) 혹은 정선한 계내금을 사용하여 녹용을 발효시킬 경우, 얻어지는 녹용 발효물의 회수율이 낮고, 녹용 발효물의 약리활성이 만족스럽지 못한 단점이 있다.However, when the antler is fermented using a conventional method, for example, Bacillus Py-92 strain (KCTC 0049 BP) isolated from animal intestinal contents or fresh stools, or the selected salary, It is low, and the pharmacological activity of the antler fermentation is not satisfactory.
본 발명자들은 약리활성이 우수한 녹용 발효물을 생산할 수 있고, 또한 회수율이 녹용 발효물의 제조방법을 개발하고자 다양한 연구를 수행하였다. 그 결과, 왕겨 또는 쌀겨로부터 새롭게 분리한 균주를 사용하여 녹용을 발효시킬 경우, 종래의 균주에 비해 수율(즉, 회수율)을 크게 높일 수 있을 뿐만 아니라, 얻어지는 녹용 발효물이 우수한 약리활성을 갖는다는 것을 발견하였다.The present inventors carried out various studies to develop a method for producing a antler fermented product having excellent pharmacological activity, and a recovery rate of the antler fermented product. As a result, when the antler is fermented using a strain newly isolated from rice bran or rice bran, not only can the yield (i.e., recovery) be significantly increased compared to the conventional strain, but the obtained antler fermented product has excellent pharmacological activity. I found that.
따라서, 본 발명은 녹용 발효 활성을 갖는 신규의 균주를 제공하는 것을 목적으로 한다.Therefore, an object of the present invention is to provide a novel strain having antler fermentation activity.
또한, 본 발명은 상기 균주를 이용한 녹용 발효물의 제조방법을 제공하는 것을 목적으로 한다.In addition, an object of the present invention is to provide a method for producing a antler fermented product using the strain.
본 발명의 일 태양에 따라, 녹용 발효 활성을 갖는 바실러스 리케니포르미스 (Bacillus licheniformis) KCCM10885P이 제공된다.According to one aspect of the present invention, Bacillus licheniformis KCCM10885P having antler fermentation activity is provided.
본 발명의 다른 태양에 따라, (a) 녹용을 함유하는 배양액 중에서 바실러스 리케니포르미스 (Bacillus licheniformis) KCCM10885P를 가하여 발효시키는 단계; 및 (b) 얻어진 발효액을 농축 또는 건조하는 단계를 포함하는 녹용 발효물의 제조방법이 제공된다.According to another aspect of the invention, (a) Bacillus rickeniformis ( Bacillus ) in a culture solution containing antler licheniformis ) fermentation by adding KCCM10885P; And (b) it provides a method for producing a antler fermentation comprising the step of concentrating or drying the obtained fermentation broth.
본 발명의 제조방법에 있어서, 상기 녹용을 함유하는 배양액으로는 녹용을 수성 매질(aqueous medium)에 분산시켜 얻어진 것을 바람직하게 사용할 수 있으며, 상기 바실러스 리케니포르미스 (Bacillus licheniformis) KCCM10885P는 바실러스 리케니포르미스 (Bacillus licheniformis) KCCM10885P를 함유하는 왕겨 또는 쌀겨의 형태로 가해질 수 있다. 또한, 상기 왕겨 또는 쌀겨는 80∼120 ℃에서 10∼30 분 동안 처리된 것을 바람직하게 사용할 수 있다.In the production method of the present invention, the culture solution containing the antler can be preferably used by dispersing the antler in an aqueous medium ( Bacillus licheniformis) ( Bacillus licheniformis ) KCCM10885P is Bacillus rickeniformis ( Bacillus) licheniformis ) can be added in the form of rice bran or rice bran containing KCCM10885P. In addition, the rice husk or rice bran can be preferably used for 10 to 30 minutes treated at 80 ~ 120 ℃.
상기 발효는 3∼15일, 바람직하게는 약 10일 동안 수행되는 것이 바람직하며, 상기 건조는 동결건조에 의해 수행되는 것이 바람직하다.The fermentation is preferably performed for 3 to 15 days, preferably about 10 days, and the drying is preferably performed by lyophilization.
본 발명에 따라 새롭게 분리된 바실러스 리케니포르미스 (Bacillus licheniformis) KCCM10885P는 높은 수율의 녹용 발효물의 제조를 가능하게 한다. 또한, 상기 균주로부터 얻어진 녹용 발효물은 종래의 균주들을 사용한 녹용 발효물에 비하여 우수한 항피로 효과, 간장보호 효과, 설사억제 효과 등의 약리활성을 갖는다. Bacillus licheniformis KCCM10885P, newly isolated according to the present invention, enables the production of a high yield of antler fermentation. In addition, the antler fermentation product obtained from the above strain has excellent anti-fatigue effect, hepatoprotective effect, diarrhea inhibitory effect and the like compared to the antler fermentation products using conventional strains.
본 발명은 녹용 발효 활성을 갖는 바실러스 리케니포르미스 (Bacillus licheniformis) KCCM10885P을 포함한다.The present invention includes Bacillus licheniformis KCCM10885P having antler fermentation activity.
본 발명자들은 전국 각지의 왕겨 및 쌀겨로부터 녹용 발효 활성을 갖는 미생물들을 다양하게 검색하였다. 즉, 왕겨 및 쌀겨를 100 ℃에서 30 분간 처리하고 이를 TSB(tryptic soy broth)에 현탁시키고, 상등액을 TSA(tryptic soy agar) 배지에 이식한 다음, 24시간 동안 37℃에서 배양하여 자라나온 콜로니에 녹용을 가하여 녹용 발효 활성을 갖는 균주를 검색하였다. The present inventors searched a variety of microorganisms having antler fermentation activity from rice bran and rice bran around the country. In other words, the rice husk and rice bran was treated for 30 minutes at 100 ℃ and suspended in TSB (tryptic soy broth), the supernatant was transplanted to TSA (tryptic soy agar) medium, and then incubated at 37 ℃ for 24 hours to grow colonies Deer Antler was added to search for strains with antler fermentation activity.
상기 검색 결과, 녹용 발효 활성을 갖는 균주를 약 20 여개 선별하였으며, 이 중에서 발효 수율(즉, 녹용 발효물의 회수율)이 가장 높을 뿐만 아니라, 이취가 나지 않는 균주를 선별하여, KH-07 균주로 명명하였다. As a result of the search, about 20 strains having antler fermentation activity were selected. Among them, the highest fermentation yield (ie, recovery rate of antler fermentation) was selected, and strains which had no off-flavor were selected and named as KH-07 strains. It was.
상기 KH-07 균주는 그람 염색에 의해 그람 양성 간균이었다. KH-07 균주의 gDNA를 Wizard genomic DNA purification kit (Promega, USA)를 이용하여 분리하고, 프라이머[정방향: 5'-TCA CCA AGG CRA CGA TGC G-3'(서열번호 2), 역방향: 5'-CGT ATT CAC CGC GGC ATG-3'(서열번호 3)]를 사용하여 PCR [94 ℃에서 5 분; 이후, 94 ℃에서 30 초(denaturation), 54 ℃에서 40 초(annealing), 및 72 ℃에서 90 초(extension)의 30 사이클]을 수행하여 1100 bp의 PCR 산물을 얻고 이를 T-easy 벡터 (Promega 사, 미국)에 접합(ligation)시킨 후 JM 109 (Promega 사)에 형질전환(transformation)하였다. Positive clone에서 플라스미드를 다시 분리해 내어 T7, SP6 프라이머를 이용하여 서열분석하였다.The KH-07 strain was Gram positive bacilli by Gram staining. GDNA of KH-07 strain was isolated using Wizard genomic DNA purification kit (Promega, USA), primer [forward: 5'-TCA CCA AGG CRA CGA TGC G-3 '(SEQ ID NO: 2), reverse: 5' PCR [5 min at 94 ° C. using CGT ATT CAC CGC GGC ATG-3 ′ (SEQ ID NO: 3)]; Thereafter, 30 cycles of 30 seconds (denaturation at 94 ° C., 40 seconds (annealing) at 54 ° C., and 90 seconds at 72 ° C.] were obtained to obtain a PCR product of 1100 bp, which was obtained using a T-easy vector (Promega). JM 109 (Promega) was transformed after ligation. Plasmids were again isolated from the positive clones and sequenced using T7 and SP6 primers.
GenBank homology search Blast system에서 얻은 KH-07 균주의 16S rDNA의 서열은 서열번호 1과 같다. 서열분석 결과, 바실러스 서브틸리스(Bacillus subtilis) 및 바실러스 리케니포르미스(Bacillus licheniformis)와 아주 유사했으며, 두 균주와 직접 비교시에는 후자에 더 유사한 특징을 보였으나 동일하지는 않았다 (하기 표 1 참조).GenBank The sequence of 16S rDNA of KH-07 strain obtained from the homology search Blast system is shown in SEQ ID NO: 1. Sequencing showed very similar characteristics to Bacillus subtilis and Bacillus licheniformis , and when compared directly with the two strains, the latter showed more similar characteristics but not identical (see Table 1 below). ).
본 발명에 따라 새롭게 분리된 KH-07 균주의 균학적 성질을 공지의 균주인 바실러스속 Py-92균주(KCTC 0049 BP), 바실러스 서브틸리스(Bacillus subtilis) KCTC1325 및 바실러스 리케니포르미스(Bacillus licheniformis) KCTC1026와 비교한 결과는 다음 표 2와 같다. According to the present invention, the bacteriological properties of the newly isolated KH-07 strain were Bacillus genus Py-92 strain (KCTC 0049 BP), Bacillus subtilis ( Kcillus subtilis). subtilis ) KCTC1325 and Bacillus rickeniformis ( Bacillus) licheniformis ) compared with KCTC1026 is shown in Table 2 below.
상기 균학적 성질로부터 KH-07 균주는 공지의 균주와 신규한 균주로 판단되며, 특히 하기 실시예에서 밝힌 바와 같이, 종래의 균주들에 비하여 우수한 녹용 발효물의 회수율을 나타내고, 얻어진 녹용 발효물이 우수한 항피로 효과, 간장보호 효과, 설사억제 효과를 나타낸다. KH-07 strains from the above bacteriological properties were determined to be known strains and novel strains, and in particular, as shown in the following examples, the antler fermented products exhibited excellent recoveries of antler fermentation products compared to conventional strains. Anti-fatigue effect, hepatoprotective effect, diarrhea inhibitory effect.
상기의 결과들을 근거로 본 발명자들은 새롭게 분리한 KH-07 균주를 2007년 10월 17일자로 한국종균협회 한국미생물보존세타 (KCCM)에 기탁하였으며, KCCM 10885P의 수탁번호를 부여받았다. Based on the above results, the present inventors deposited the newly isolated KH-07 strain on the Korea Microbiological Preservation Theta (KCCM) on October 17, 2007, and received an accession number of KCCM 10885P.
본 발명은 KH-07 균주를 이용한 녹용 발효물의 제조방법을 포함한다. 즉, 본 발명은 (a) 녹용을 함유하는 배양액 중에서 바실러스 리케니포르미스 (Bacillus licheniformis) KCCM10885P를 가하여 발효시키는 단계; 및 (b) 얻어진 발효액을 농축 또는 건조하는 단계를 포함하는 녹용 발효물의 제조방법을 포함한다.The present invention includes a method for producing antler fermented product using KH-07 strain. That is, the present invention (a) Bacillus licheniformis ( Bacillus licheniformis ) KCCM10885P step of fermentation in the culture solution containing antler; And (b) comprises a method for producing a antler fermentation comprising the step of concentrating or drying the obtained fermentation broth.
본 명세서에서, 상기 "녹용"은 사슴과(cervidae)에 속하는 매화록, 마록 또는 기타 종속의 수사슴의 머리에 난 골질화되지 않은 어린 뿔을 말하며, 별도로 표기하지 않는 한 녹각, 낙각 등을 모두 포함한다. 상기 녹용은 통상의 방법에 따라 분쇄하거나, 주정에 담궈 두었다가 절단하여 건조한 것을 모두 포함한다. As used herein, the term "deer antler" refers to a young horn that is not ossified in the head of plum, marok or other dependent stag, belonging to a cervidae, and includes all kinds of rust, fall, etc. unless otherwise indicated. do. The antler may include all those ground or dried by cutting in a conventional manner or dipped in alcohol.
본 발명의 제조방법에 있어서, 상기 녹용을 함유하는 배양액은 녹용을 수성 매질(aqueous medium), 예를 들어 물에 분산시켜 얻어진 것을 바람직하게 사용할 수 있다. 상기 물 등의 수성 매질의 사용량은 크게 제한된 것은 아니며, 예를 들어, 녹용에 대하여 약 10배 중량의 물을 사용할 수 있다.In the production method of the present invention, the culture solution containing the antler may be preferably one obtained by dispersing the antler in an aqueous medium, for example, water. The amount of the aqueous medium such as water is not particularly limited, and for example, water of about 10 times the weight of antler may be used.
상기 바실러스 리케니포르미스 (Bacillus licheniformis) KCCM10885P는 균체를 그대로 가하거나 스타터 형태로 가할 수 있다. 균체를 그대로 가하는 경우, 균체의 함량은 예를 들어, 10만 ∼ 100만개를 가할 수 있으나, 크게 제한되는 것은 아니다. Bacillus rickenformis ( Bacillus) licheniformis ) KCCM10885P can be added as is or in starter form. When the cells are added as it is, the content of the cells can be added, for example, 100,000 to 1 million, but is not significantly limited.
또한, 바실러스 리케니포르미스 (Bacillus licheniformis) KCCM10885P를 스타터 형태로 가하는 경우, 상기 균주를 왕겨 또는 쌀겨에 접종하여 가할 수 있다. 상기 스타터는 통상의 왕겨 또는 쌀겨 10 g에 대하여 바실러스 리케니포르미스 (Bacillus licheniformis) KCCM10885P 약 1 X 105개를 가함으로써 얻을 수 있으나, 상기 접종되는 균주의 수는 크게 제한되는 것은 아니다. 바람직하게는 상기 스타터 형태의 왕겨 또는 쌀겨를 80∼120 ℃에서 10∼30 분 동안 처리하여 사용할 경우, 녹용 발효물의 수율을 높일 수 있고, 발효 시 불쾌한 냄새 및 맛을 감소시킬 수 있다. In addition, Bacillus rickenformis ( Bacillus) licheniformis ) When KCCM10885P is added in the form of a starter, the strain may be added by inoculating chaff or rice bran. The starter can be obtained by adding about 1 × 10 5 Bacillus licheniformis KCCM10885P to 10 g of conventional rice husk or rice bran, but the number of strains inoculated is not greatly limited. Preferably, when the starter-type chaff or rice bran is used after treatment at 80 to 120 ° C. for 10 to 30 minutes, the yield of the antler can be increased, and an unpleasant smell and taste can be reduced during fermentation.
상기 발효는 실온(즉, 약 25 ℃) 또는 약 37 ℃에서 수행될 수 있으며, 3∼15일, 바람직하게는 약 10일 동안 수행될 수 있다.The fermentation may be performed at room temperature (ie, about 25 ° C.) or about 37 ° C., and may be performed for 3 to 15 days, preferably about 10 days.
본 발명의 제조방법은 상기와 같이 얻어진 발효액을 농축 또는 건조하는 단계[단계(b)]를 포함한다. 상기 농축은 통상의 감압농축 등의 방법을 사용할 수 있으며, 상기 건조는 감압건조, 동결건조 등의 방법을 사용할 수 있다. 바람직하게는 상기 건조는 동결건조에 의해 수행될 수 있다.The production method of the present invention comprises the step of concentrating or drying the fermentation broth obtained as described above (step (b)). The concentration may be a conventional method such as concentrated under reduced pressure, the drying may be a method such as reduced pressure drying, freeze drying. Preferably the drying may be carried out by lyophilization.
이하 본 발명을 실시예를 통하여 더욱 상세히 설명한다. 그러나, 하기 실시예는 본 발명을 예시하기 위한 것으로, 본 발명의 범위를 제한하는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples. However, the following examples are intended to illustrate the invention, but not to limit the scope of the invention.
실시예Example 1. One. KHKH -07 균주가 접종된 왕겨 및 쌀겨를 이용한 녹용의 발효-07 Fermentation of Deer Antler Using Rice Bran and Rice Bran Inoculated with Strain
KH-07 균주 1 X 104개를 왕겨 또는 쌀겨 1 g에 접종하고, 그대로(즉 실온) 혹은 60 ℃, 80 ℃, 100 ℃, 120 ℃의 오븐에서 각각 30분 동안 처리하였다. 세절된 녹용 100 g에 10 배량의 물을 넣고, 상기에서 준비한 KH-07 균주가 접종된 왕겨 또는 쌀겨를 가한 후, 37 ℃에서 10일 동안 배양하였다. 배양액을 여과하여 고형물을 제거하고, 동결건조하여 녹용 발효물을 제조하였다.1 X 10 4 KH-07 strains were inoculated into 1 g of rice husk or rice bran and treated as is (ie room temperature) or in an oven at 60 ° C., 80 ° C., 100 ° C., 120 ° C. for 30 minutes each. 10 times of water was added to 100 g of cut antler, and the inoculated rice hull or rice bran inoculated with the KH-07 strain prepared above was incubated at 37 ° C for 10 days. The culture solution was filtered to remove solids and lyophilized to prepare a antler fermented product.
각각의 처리 조건에 따른 녹용 발효물의 수율 및 불쾌한 냄새 및 맛의 정도를 측정한 결과는 다음 표 3과 같다. 녹용 발효물의 수율은 녹용을 발효시키고 여과하여 동결건조시켜 얻은 것을 원 녹용의 대비하여 계산하였다.The results of measuring the yield of the antler fermentation and the degree of unpleasant odor and taste according to the respective treatment conditions are shown in Table 3 below. Yield of antler antler was calculated by fermenting antler, filtering and lyophilization of raw antler.
-없음; + 약함; ++, 보통; +++, 강함-none; + Weak; ++, normal; +++, strong
실시예Example 2. 2. KHKH -07 균주가 접종된 왕겨 및 쌀겨를 이용한 녹용의 발효-07 Fermentation of Deer Antler Using Rice Bran and Rice Bran Inoculated with Strain
세절된 녹용 대신 세절된 녹각을 사용한 것을 제외하고는 실시예 1과 동일한 과정을 수행하여 녹용 발효물을 제조하였으며, 각각의 처리 조건에 따른 녹용 발효물의 수율 및 불쾌한 냄새 및 맛의 정도를 측정한 결과는 다음 표 4와 같다. 녹용 발효물의 수율은 녹용을 발효시키고 여과하여 동결건조시켜 얻은 것을 원 녹용의 대비하여 계산하였다.Except for using the fragmented rust rust instead of the fragmented antler was carried out in the same manner as in Example 1 to prepare a antler fermented product, the results of measuring the yield and unpleasant smell and taste of the antler fermentation according to the respective treatment conditions Is shown in Table 4 below. Yield of antler antler was calculated by fermenting antler, filtering and lyophilization of raw antler.
-없음; + 약함; ++, 보통; +++, 강함-none; + Weak; ++, normal; +++, strong
상기 실시예 1 및 2의 결과로부터 왕겨 또는 쌀겨를 스타터로서 사용하여 발효시킬 경우, 80∼120 ℃에서 10∼30 분 동안 처리하여 사용하는 것이 바람직함을 알 수 있다.From the results of Examples 1 and 2 it can be seen that when fermented using chaff or rice bran as a starter, it is preferable to use for 10 to 30 minutes treatment at 80 ~ 120 ℃.
실시예Example 3. 녹용 추출물의 수율 및 약리효과 측정 3. Measurement of yield and pharmacological effect of antler extract
녹용을 수욕 상에서 그대로 추출하고 추출액을 동결건조한 시험군(제1 시험군), 바실러스 Py-92 균주를 사용하여 발효를 수행하여 얻어진 발효액을 동결건조하여 얻어진 시험군(제2 시험군), 계내금을 사용하여 발효를 수행하여 얻어진 발효액을 동결건조하여 얻어진 시험군(제3 시험군), KH-07 균주를 접종한 왕겨를 스타터로 사용하여 발효를 수행하여 얻어진 발효액을 동결건조하여 얻어진 시험군(제4 시험군), KH-07 균주를 접종한 쌀겨를 스타터로 사용하여 발효를 수행하여 얻어진 발효액을 동결건조하여 얻어진 시험군(제5 시험군), 및 KH-07 균주를 직접 가하여 발효를 수행하여 얻어진 발효액을 동결건조하여 얻어진 시험군(제6 시험군)을 대상으로 수율 및 약리효과를 측정하였다. 각각의 시험군은 구체적으로 다음과 같다.A test group (1st test group), which was extracted as it was on a water bath, and the extract was lyophilized, a test group (2nd test group) obtained by lyophilizing a fermentation broth obtained by fermentation using a Bacillus Py-92 strain, and a sediment Test group obtained by lyophilizing the fermentation broth obtained by carrying out the fermentation using a test group (third test group), and a test group obtained by lyophilizing the fermentation broth obtained by performing fermentation using a chaff inoculated with the KH-07 strain as a starter ( 4th test group), a test group obtained by lyophilizing a fermentation broth obtained by fermentation using a rice bran inoculated with KH-07 strain as a starter (5th test group), and the KH-07 strain was directly added to carry out fermentation. The yield and pharmacological effects were measured for the test group (sixth test group) obtained by freeze-drying the fermentation broth. Each test group is specifically as follows.
제1 시험군: 녹용(100 g)에 물 1 liter를 넣어 수욕상에서 4시간 추출하고 동결건조하여 얻어진 추출물 (수율 4.1%)1st test group: Extract obtained by adding 1 liter of water to deer antler (100 g), extracting in water bath for 4 hours, and freeze drying (yield 4.1%)
제2 시험군: 녹용 (100 g)에 물 1 liter를 넣고 바실러스 Py-92 균주(1 X 104 개)를 가하고 10 일간 발효시키고, 멸균한 후 여과하여 얻은 여액을 동결건조하여 얻어진 발효물 (수율 17%)Second test group: Fermented product obtained by adding 1 liter of water to deer antler (100 g), adding Bacillus Py-92 strain (1 X 10 4 strains), fermenting for 10 days, sterilizing, and filtering and filtering the filtrate. Yield 17%)
제3 시험군: 녹용 (100 g)에 물 1 liter를 넣고 계내금 (100 g)을 넣고 42 ℃에서 10 일간 발효시키고, 멸균한 후 여과하여 동결건조하여 얻어진 발효물 (수율 15%)3rd test group: Fermented product obtained by adding 1 liter of water to deer antler (100 g), adding sediment (100 g), fermenting at 42 ° C. for 10 days, sterilizing, filtration and lyophilization (yield 15%).
제4 시험군: 녹용(100 g)에 물을 1 liter를 넣고 KH-07 균주가 1 X 104 개 접종된 왕겨 (100 ℃에서 30분 동안 처리) 1 g을 넣고 37 ℃에서 10일간 발효시키고, 상등액을 동결건조하여 얻어진 발효물 (수율 31%)4th test group: 1 liter of water was added to deer antler (100 g), 1 g of rice hulls (treated for 30 minutes at 100 ° C) inoculated with 1 X 10 4 strains of KH-07 strain and fermented at 37 ° C for 10 days. , Fermented product obtained by lyophilization of supernatant (yield 31%)
제5 시험군: 녹용(100 g)에 물을 1 liter를 넣고 KH-07 균주가 1 X 104 개 접종된 쌀겨 (100 ℃에서 30분 동안 처리)을 1 g을 넣고 37 ℃에서 10일간 발효시키고, 상등액을 동결건조하여 얻어진 발효물 (수율 35%)Test group 5: 1 liter of water was added to antler (100 g), and 1 g of rice bran (treated for 30 minutes at 100 ° C.) inoculated with 1 × 10 4 KH-07 strains was fermented at 37 ° C. for 10 days. Fermented product obtained by lyophilization of supernatant (yield 35%)
제6 시험군: 녹용(100 g)에 물을 1 liter를 넣고 KH-07 균주 1 X 104 개를 가하여, 37 ℃에서 10일간 발효시키고, 상등액을 동결건조하여 얻어진 발효물 (수율 34%)6th test group: Fermented product obtained by adding 1 liter of water to deer antler (100 g) and adding 1 × 10 4 strains of KH-07 strains for 10 days at 37 ° C. and freeze-drying the supernatant (yield 34%).
(1) 수율 측정(1) yield measurement
제1군 내지 제6군의 발효물에 대한 녹용 추출물의 회수율(수율)은 다음 표 5와 같다.Recovery rate (yield) of the antler extract for the fermented products of the first to sixth group is shown in Table 5 below.
(2) (2) 항피로Antifatigue 효과 effect
25x40x17 cm의 투명한 플라스틱 용기에 증류수를 14 cm까지 채우고 항온조의 온도를 18 ℃로 유지하면서 10개의 수영조에서 동시에 수영시간을 측정하였다. 수영실험은 체중을 달고 체중에 8%의 납줄을 달아 목의 배면 부위에 고정하고 생리식염수를 투여한 대조군, 각각의 시료를 용량별로 투여한 군 모두 경구투여 30분이 경과한 시점에서 동시에 수영을 시켰으며, 수영 종료시간은 코가 수면 아래로 잠길 정도의 수영이 5초가 진행되어 가라앉게 될 때까지의 수영시간를 측정하여 수영가능시간으로 하여 계산하였다. 종료된 생쥐의 혈액을 즉시 채취하여 혈중 크레아틴 양을 측정하였다. 각각의 군을 10마리로 하였으며, 시료는 kg 당 20 mg 또는 50 mg을 투여하였다. 그 결과는 다음 표 6과 같다.A 25 x 40 x 17 cm transparent plastic container was filled with distilled water up to 14 cm and the swimming time was measured simultaneously in 10 swimming baths while maintaining the temperature of the thermostat at 18 ° C. In the swimming experiment, weights, weights of 8% were attached to the back of the neck, fixed to the back of the neck, physiological saline-controlled, and groups administered with each sample were allowed to swim at the same time 30 minutes after oral administration. And, the end time of swimming was calculated by measuring the swimming time until the swimming is enough to sink to the nose enough to be submerged under the surface of the water as a swimming time. The blood of the terminated mice was immediately taken and the amount of creatine in the blood was measured. Each group was made up of 10 rats and the samples were administered 20 mg or 50 mg per kg. The results are shown in Table 6 below.
상기 표 6의 결과로부터 알 수 있는 바와 같이, 본 발명에 따라 제조된 녹용 발효물은 종래의 균주를 사용하여 제조한 녹용 발효물에 비해 우수한 항피로 효과를 갖는다.As can be seen from the results of Table 6, the antler fermentation prepared according to the present invention has an excellent anti-fatigue effect compared to the antler fermentation prepared using a conventional strain.
(3) 간장 손상 보호 효과 (3) hepatic damage protection effect
랫트 (웅성, 180-200 그램) 1군을 5마리로 하여 100그램당 20% 사염화탄소 (올리브유로 희석)을 1 ml 씩 경구투여하고 30분 후에 각각의 시험군에 따른 녹용 또는 녹용발효물을 경구투여하였다. 사염화 탄소 투여 24시간 후에 심장으로부터 채혈하여 혈중 AST(aspartate aminotransferase) 및 ALT(alanine aminotransferase) 농도를 측정하였다. 그 결과는 다음 표 7과 같다.Five rats (Woongseong, 180-200 grams) were administered orally with 1 ml of 20% carbon tetrachloride (diluted with olive oil) per 100 grams. Administered. 24 hours after the administration of carbon tetrachloride, the blood was collected from the heart and the concentrations of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were measured. The results are shown in Table 7 below.
상기 표 7의 결과로부터, 사염화탄소로 랫트에 간손상을 유발시킨 결과 혈중 ALT, AST가 증가하였으나, 녹용 및 발효 녹용 처리군에서 간손상을 개선하였으나 왕겨, 쌀겨 또는 이로부터 분리한 KH-07로 발효시킨 녹용 발효물이 강한 간장 보호효과를 나타냄을 알 수 있다.From the results of Table 7 above, as a result of causing liver damage to rats with carbon tetrachloride, blood ALT and AST increased, but liver damage was improved in the antler and fermented antler treated groups, but fermented with rice hull, rice bran or KH-07 isolated therefrom. It can be seen that the deer antler fermented product has a strong soy protective effect.
(4) 급성 독성 시험(4) acute toxicity test
6 주령의 특정 병원체 부재(specific pathogen-free, SPF) SD계 랫트를 사용하여 급성 독성 시험을 실시하였다. 각 그룹 당 5 마리씩의 동물에 본 발명의 발효녹용추출물을 0.5, 1 및 2 g/㎏의 용량으로 1회 경구투여 하였다. 시험 물질 투여 후 동물의 폐사여부, 임상증상 및 체중변화를 관찰하고 혈액학적 검사와 혈액생화학적 검사를 실시하였으며, 부검하여 육안으로 강장기와 흉강 장기의 이상여부를 관찰하였다.Acute toxicity testing was performed using 6-week-old specific pathogen-free (SPF) SD rats. Five animals of each group were orally administered fermented antler extract of the present invention at doses of 0.5, 1 and 2 g / kg. After administration of the test substance, mortality, clinical symptoms, and changes in body weight were observed, and hematological and hematological examinations were performed.
시험 결과, 시험 물질을 투여한 모든 동물에서 특이할 만한 임상증상이나 폐사된 동물은 없었으며, 체중변화, 혈액검사, 혈액생화학 검사 및 부검 소견 등에서도 독성변화는 관찰되지 않았다. 그러나, 제1 시험군(녹용) 및 제2 시험군(계내금발효 녹용) 투여군에서 설사가 관찰되었다. 이상의 결과, 본 발명에 따라 제조된 녹용 발효물은 랫트에서 각각 2 g/㎏까지도 독성변화를 나타내지 않았으며, 경구투여 최소치사량(LD50)은 2 g/㎏이상인 안전한 물질로 판단된다.As a result, there were no clinical symptoms or dead animals in all animals treated with the test substance, and no toxicity change was observed in weight change, blood test, blood biochemical test and autopsy findings. However, diarrhea was observed in the first test group (deer antler) and the second test group (internal fermentation antler). As a result, the antler fermentation prepared according to the present invention did not show a change in toxicity even in rats up to 2 g / kg, and the minimum lethal dose (LD 50 ) is determined to be a safe substance of 2 g / kg or more.
(5) 설사 (5) diarrhea 발생율Incidence 및 수분함량 측정 And moisture content measurement
생쥐 (ICR 웅성, 20-22g)를 한군 10마리로 하여 생리식염수 0.5 ml에 현탁한 녹용과 녹용 발효물을 각각 0.5g/kg 또는 1g/kg씩 투여하여 설사발생율 및 분변 중 수분함량을 측정하였다. 대조약물로는 망초를 사용하였다. 그 결과는 다음 표 8과 같다.10 mice (ICR male, 20-22g) were used in one group, and 0.5g / kg or 1g / kg of antler and antler fermented in 0.5 ml of saline solution were administered, respectively, and the incidence of diarrhea and water content in feces were measured. . Forage was used as a control drug. The results are shown in Table 8 below.
* 분변 중의 수분의 함량이 75% 이상인 경우는 핀셋으로 집기가 어려운 설사형태임* Diarrhea that is difficult to pick up with tweezers when the water content in the feces is more than 75%
(6) 약리효과의 종합(6) Synthesis of Pharmacological Effects
상기한 약리효과 시험결과를 종합하면, 다음 표 9와 같다. The results of the above pharmacological effects test are summarized in Table 9 below.
-, 효과 없음-, no effect
+, 약함; ++, 보통임; +++, 강함+, Weak; ++, normal; +++, strong
실시예Example 4. 공지의 4. Notice 바실러스속와의With Bacillus 비교 compare
녹용(100 g)에 물을 1 liter를 넣고 KH-07 균주, 바실러스 서브틸리스(Bacillus subtilis) KCTC1325 및 바실러스 리케니포르미스(Bacillus licheniformis) KCTC1026 균주를 각각 1 X 104 개를 가하여, 37 ℃에서 10일간 발효시키고, 상등액을 동결건조하여 녹용 발효물을 얻었다. 얻어진 녹용 발효물을 가지고 상기 (2)와 동일한 방법으로 항피로효과를 측정하였다. 각각의 수율 및 항피로 효과를 측정한 결과는 다음 표 10과 같다.Add 1 liter of water to Deer Antler (100 g) and strain KH-07, Bacillus subtilis subtilis ) KCTC1325 and Bacillus licheniformis KCTC1026 strains were added to 1 × 10 4 strains, respectively, and fermented at 37 ° C. for 10 days, and the supernatant was lyophilized to obtain a antler fermented product. The anti-fatigue effect was measured with the obtained antler fermented product in the same manner as in (2) above. The results of measuring the yield and the anti-fatigue effect are shown in Table 10 below.
상기 결과로부터, 본 발명에 따라 새롭게 분리된 KH-07 균주는 종래의 균주들에 비하여 우수한 녹용 발효물의 회수율을 나타내고, 얻어진 녹용 발효물이 우수한 약리효과를 나타냄을 알 수 있다. From the above results, it can be seen that the newly isolated KH-07 strain according to the present invention shows excellent recovery rate of antler fermentation, and the obtained antler fermentation exhibits excellent pharmacological effect compared to the conventional strains.
서열목록 전자파일 첨부 Attach sequence list electronic file
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070114060A KR100808060B1 (en) | 2007-11-09 | 2007-11-09 | Microorganism having fermentation activity of cervi parvum cornu and process for the preparation of fermentation product of cervi parvum cornu using the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070114060A KR100808060B1 (en) | 2007-11-09 | 2007-11-09 | Microorganism having fermentation activity of cervi parvum cornu and process for the preparation of fermentation product of cervi parvum cornu using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100808060B1 true KR100808060B1 (en) | 2008-02-28 |
Family
ID=39383542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070114060A KR100808060B1 (en) | 2007-11-09 | 2007-11-09 | Microorganism having fermentation activity of cervi parvum cornu and process for the preparation of fermentation product of cervi parvum cornu using the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100808060B1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101039887B1 (en) | 2009-07-22 | 2011-06-09 | 광동제약 주식회사 | Cordyceps.sp having fermentation activity of cervi parvum cornu and process for the preparation of fermentation extraction of cervi parvum cornu using this |
KR101090657B1 (en) | 2009-07-22 | 2011-12-07 | 광동제약 주식회사 | Bacillus.sp having fermentation activity of cervi parvum cornu and process for the preparation of fermentation extraction of cervi parvum cornu using this |
KR101096642B1 (en) * | 2011-04-05 | 2011-12-21 | 김중순 | The fermenting method of antlers which use mushroom concentrates |
KR101184359B1 (en) | 2010-03-23 | 2012-09-20 | 광동제약 주식회사 | Composition having antioxidative and growth promoting function which comprises Bacillus subtilis KCTC 11454BP as an active ingredient, and a preparation method thereof |
KR101184349B1 (en) | 2010-03-23 | 2012-09-21 | 광동제약 주식회사 | Composition for enhancement of immune function and improvement of hematopoiesis which comprises antler fermented with Bacillus subtilis KCTC 11454BP as an active ingredient, and a preparation method thereof |
KR101184355B1 (en) | 2010-03-23 | 2012-09-21 | 광동제약 주식회사 | Composition for enhancement of immune function and improvement of hematopoiesis which comprises antler fermented with Cordyceps militaris KCTC 11455BP as an active ingredient, and a preparation method thereof |
KR101269974B1 (en) | 2010-10-11 | 2013-05-31 | 주식회사 녹계마루 | Method for Producing a Solution Cultured by Deer Antlers With Eco-Friendly Property |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100206182B1 (en) | 1992-08-11 | 1999-07-01 | 박주석 | A novel bacillus sp and its selecting method |
KR100329365B1 (en) | 1998-09-23 | 2002-09-25 | 이연수 | Antlers of the deer fermented with chicken gizzard lining and their method of preparation |
KR20060018483A (en) * | 2004-08-24 | 2006-03-02 | 김한복 | Powdered chungkook-jang composition for hypotension |
KR20060128117A (en) * | 2005-06-09 | 2006-12-14 | 김현수 | A composition comprising the fermented velvet antlers extract |
-
2007
- 2007-11-09 KR KR1020070114060A patent/KR100808060B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100206182B1 (en) | 1992-08-11 | 1999-07-01 | 박주석 | A novel bacillus sp and its selecting method |
KR100329365B1 (en) | 1998-09-23 | 2002-09-25 | 이연수 | Antlers of the deer fermented with chicken gizzard lining and their method of preparation |
KR20060018483A (en) * | 2004-08-24 | 2006-03-02 | 김한복 | Powdered chungkook-jang composition for hypotension |
KR20060128117A (en) * | 2005-06-09 | 2006-12-14 | 김현수 | A composition comprising the fermented velvet antlers extract |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101039887B1 (en) | 2009-07-22 | 2011-06-09 | 광동제약 주식회사 | Cordyceps.sp having fermentation activity of cervi parvum cornu and process for the preparation of fermentation extraction of cervi parvum cornu using this |
KR101090657B1 (en) | 2009-07-22 | 2011-12-07 | 광동제약 주식회사 | Bacillus.sp having fermentation activity of cervi parvum cornu and process for the preparation of fermentation extraction of cervi parvum cornu using this |
KR101184359B1 (en) | 2010-03-23 | 2012-09-20 | 광동제약 주식회사 | Composition having antioxidative and growth promoting function which comprises Bacillus subtilis KCTC 11454BP as an active ingredient, and a preparation method thereof |
KR101184349B1 (en) | 2010-03-23 | 2012-09-21 | 광동제약 주식회사 | Composition for enhancement of immune function and improvement of hematopoiesis which comprises antler fermented with Bacillus subtilis KCTC 11454BP as an active ingredient, and a preparation method thereof |
KR101184355B1 (en) | 2010-03-23 | 2012-09-21 | 광동제약 주식회사 | Composition for enhancement of immune function and improvement of hematopoiesis which comprises antler fermented with Cordyceps militaris KCTC 11455BP as an active ingredient, and a preparation method thereof |
KR101269974B1 (en) | 2010-10-11 | 2013-05-31 | 주식회사 녹계마루 | Method for Producing a Solution Cultured by Deer Antlers With Eco-Friendly Property |
KR101096642B1 (en) * | 2011-04-05 | 2011-12-21 | 김중순 | The fermenting method of antlers which use mushroom concentrates |
WO2012138057A2 (en) * | 2011-04-05 | 2012-10-11 | Kim Young-Hee | Method for fermenting antlers, venison, or deer bones using mushrooms, and resultant fermented products |
WO2012138057A3 (en) * | 2011-04-05 | 2012-11-29 | Kim Young-Hee | Method for fermenting antlers, venison, or deer bones using mushrooms, and resultant fermented products |
CN103429099A (en) * | 2011-04-05 | 2013-12-04 | 金英姬 | Method for fermenting antlers, venison, or deer bones using mushrooms, and resultant fermented products |
JP2014508530A (en) * | 2011-04-05 | 2014-04-10 | ヨンヒ キム | Fermentation method of deer rice cake, venison meat or deer bone using mushroom and fermented product thereof |
CN103429099B (en) * | 2011-04-05 | 2014-12-03 | 金英姬 | Method for fermenting antlers, venison, or deer bones using mushrooms, and resultant fermented products |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102500894B1 (en) | Lactic acid bacteria and their uses | |
KR100808060B1 (en) | Microorganism having fermentation activity of cervi parvum cornu and process for the preparation of fermentation product of cervi parvum cornu using the same | |
Dharmaraj et al. | Evaluation of Streptomyces as a probiotic feed for the growth of ornamental fish Xiphophorus helleri | |
EP1142988B1 (en) | Novel microorganism and use thereof | |
CN109694886B (en) | Green tea fermentation filtrate and preparation method and application thereof | |
CN1769426A (en) | Pentose lactobacillus bacteriocin and its special production strain and uses | |
CN114231473B (en) | Probiotic lactobacillus plantarum and application thereof in preparation of low-salt fermented meat food | |
KR100919070B1 (en) | Process for the preparation of fermentation product of esculent roots using microorganism having fermentation activity of saponin-containing esculent roots | |
CN102618452B (en) | Preparation method, composition and application of lactobacillus salivarius and its metabolites | |
CN113604395A (en) | Lactobacillus plantarum capable of fermenting dendrobium and improving skin quality by fermentation liquor of dendrobium | |
JP4313615B2 (en) | Novel lactic acid bacteria having immunostimulatory activity and γ-aminobutyric acid producing ability, and use thereof. | |
EP2537523B1 (en) | Prophylactic/ameliorating agent for diseases, endurance improving agent and anti-fatigue agent, and pharmaceutical agent, food and beverage each comprising any one of those agents | |
CN100558883C (en) | New bacterial strain with genus bifidobacterium of the ability that produces glutamine | |
JP5128020B2 (en) | Marine-derived Bacillus barbaricus SCSIO02429 and method for preparing squid oligopeptide using the same | |
KR20200067075A (en) | Fermented product of Protaetia brevitarsis extract, its preparation method and use | |
CN114292765B (en) | Bacillus subtilis and natto subspecies R3 and application thereof in fermented leech low-temperature dried product | |
CN110547384A (en) | small yellow croaker ossein antibacterial peptide and application thereof | |
KR101448496B1 (en) | Ultra High Pressure and Fermented extract of Antler and Preparing Method thereof | |
KR101976503B1 (en) | Medium composition for enhancing alcohol fermentation comprising leaf of yam and alcoholic beverage using the same | |
KR102315879B1 (en) | Novel Rhizopus oligosporus strain and antibacterial and antifungal composition comprising the same | |
KR20100089406A (en) | Bacillus polyfermenticus separated from meju and a antifungal composition comprising the same | |
CN111718857B (en) | Culture method of sparassis crispa, sparassis crispa dry powder, solvent extract and application thereof | |
KR101672098B1 (en) | Composition for removing hangover comprising fermented rice rinse water | |
CN114317628A (en) | Low-irritation gamma-aminobutyric acid product, preparation method thereof and application of reducing irritation | |
JP2006158396A (en) | Novel lactic acid bacterium strain for producing cactus lactic acid fermentation product and method for producing cactus fermentation product by using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130220 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20140307 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20150224 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20151224 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20170222 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20180116 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20190627 Year of fee payment: 12 |